Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-06-20
1998-12-29
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514213, 540491, 540523, A61K 5155
Patent
active
058542337
ABSTRACT:
Liver diseases, such as cirrhosis of the liver, toxic and medicamentary liver damage, a liver-parenchymic disorder or hepatitis, are treated by administering to a human or animal subject in need thereof a therapeutically active or prophylactically effective low dose amount of a vasodilating agent which selectively increases the supply of oxygenated blood to the liver by increasing hepatic arterial inflow. Suitable vasodilating agents include calcium blockers, such as a benzothiazepine derivative, nifedipine, felodipine or verapamil.
REFERENCES:
patent: 4902684 (1990-02-01), Floyd et al.
patent: 5569678 (1996-10-01), Lee
Marteau et al., "Effect of Vasodilators on Hepatice Microcirculation: A Study of the Inhibition of Norepinephrine-Induced Vasoconstriction in the Isolated Perfused Rat Liver", Hepatology, vol. 8, No. 2, 1988, pp. 228-231, XP000673345.
Marteau et al., "Effect of Vasodilators on Hepatic Microcirculation in Cirrhosis: A Study in the Isolated Perfused Rat Liver", Hepatology, Vo. 9, No. 6, pp. 820-823, XP000673346 (1989).
Hierlinger, "Chronic Verapamil Administration Improves Liver Function and Diffusional Exchange in a Rat Model of Liver of Liver Cirrhosis", J. Hepatol., No. Suppl. 2, 1985, p. S253, XP0002030787.
Ramanao et al., "Alterazione degli enzimi epactici in corso di terapia con diltiazem", G. Ital. Cardiol., vol. 17, No. 2, 1987, pp. 149-150, XP000673314.
Navasa et al., "Effects of Verapamil on Hepatic and Systemic Hemodynamis and Liver Function in Patients with Cirrhosis and Portal Hypertension", Hepatology, vol. 8, No. 4, 1988, pp. 850-854, XP000673312.
Merkel et al., "Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis", Br. J. Clin. Pharmacol., vol. 30, No. 2, 1990, pp. 221-228, XP000673273.
Gasic et al., "Comparative effects of verapamil, taipamil, diltiazem and nifedipine on systemic and splanchnic hemodynamis in man", Int. J. Clin. Pharmacol., Ther. Toxicol., vol. 25, No. 9, 1987, pp. 498-503, XP000673344.
MacMathuna et al., "Vasopressin-nifedipine: a favourable haemodynamic interaction in cirrhosis and portal hypertension", Eur. J. Gastroenterol. Hepatol, vol. 5, No. 10, 1993, pp. 853-857, XP000673271.
Extract from The Merck Manual of Diagnosis and Therapy, 16th Edition; Merck Research Laboratories; Ch. 286, pp. 2670-2671 (1989).
Rosman "Viral hepatitis anc alcoholism" Alcohol, health & Research World, v.16, p. 48, 1992.
Dorland's Medical dictionary, p. 1979, 1992.
Mountcastle "Medical physiology" p. 239, 1968.
Bhathal et al. "Reduction of the increased portal vascular resistance of the isodlated perfused cirrhotic rat liver by vasodilator" CA 103:189411, 1985.
Wyngaarden "Textbook of medicine" Sanders Co. pp. 779, 786, 787, 1983.
Hubert J. Stein et al., "Effect of Verpamil on Hepatic Ischemia/Reperfusion Injury", The American Journal of Surgery, vol. 165, Jan. 1993, pp. 96-100.
Decai Liang et al., "Protective Effects of the Calcium Antagonists Diltiazem and TA3090 Against Hepatic Injury Due to Hypoxia", Biochemical Pharmacology, vol. 44, No. 11, pp. 2207-2211, 1992.
David Le Courteur et al., "Aging and the Response of the Isolated Perfused Rat Liver to Vasoactive Drugs", Biochemical Pharmacology, vol. 43, No. 4, pp. 913-915, 1992.
Nobuyuki Ogawa et al., "Comparison of KRN2391 with Nicorandil and Nifedipine on Canine Coronary Blood Flow: Antagonims by Glibemclamide", Journal of Cardiovascular Pharmacology, pp. 11-17, 1992.
Stephen Cheng, et al., "Verapamil Improves Rat Hepatic Preservation with UW Solution", Journal of Surgical Research 50, pp. 560-564, 1991.
William G. Reiss et al., "The Effects of Oral Nifedipine on Hepatic Blood Flow in Humans", Clinical Pharmacology and Therapeutics, vol. 50, pp. 379-384, Oct. 1991.
Jiri Heller et al., "The effect of two different calcium antagonists on the glomerular haemodynamics in the dog", European Journal of Physiology (Berlin), vol. 415, No. 6, pp. 751-755, 1990.
Denis B. Buxton, "Potentiation of the glycogenolytic and haemodynamic actions of adenosine in the perfused rat liver by verapamil", European Journal of Pharmacology, 146 pp. 121-127, 1988.
J. Reichene et al., "Verapamil Favorably Influences Hepatic Microvascular Exchange and Functions in Rats with Cirrhosis of the Liver", The American Society for Clinical Investigation, Inc., vol. 78, Aug. 1986, pp. 448-455.
P.A. Meredith et al., "Verapamil Pharmacokeinetics and Apparent Hepatic and Renal Blood Flow", British Journal of Clinical Pharmacology, vol. 20, No. 2, 1985, pp. 101-106.
Patent Abstract of Japan JP 5-59028, Yoshiaki Oshida, "Benzothiazepine Derivative, its Salt and Medicine Composition Containing the Same", Sep. 3, 1993.
Patent Abstract of Japan JP 56-68619, Yamanouchi Seiyaku, "Nifedipine-Containing Solid Composition", 9 Jun. 1981.
Chang Ceila
Pharmacy and Therapeutic Advisory Consultancy Ltd.
LandOfFree
Method of treating liver disease and like indications with vasod does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating liver disease and like indications with vasod, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating liver disease and like indications with vasod will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1424981